A CDC official who led the agency's network to study hospitalization trends from infectious diseases like COVID-19 has resigned in protest following Health and Human Services Secretary Robert F. Kennedy Jr.'s orders to change the agency's vaccine recommendations and the committee that makes them. Dr. Fiona Havers' last day at the CDC was Monday, according to an announcement sent by an agency official to her branch within the agency's Coronavirus and Other Respiratory Viruses Division. They received the notice shortly after Reuters first reported on the resignation.
The 'One Big Beautiful Bill Act' that was passed by House Republicans and is currently being discussed by the U.S. Senate is viewed unfavorably by a majority of adults (64%), including large majorities of independents and Democrats.
The pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its potential for harsh side effects. Antibody-drug conjugates (ADCs) have taken major strides in recent years, as companies including AstraZeneca, Daiichi Sankyo, Pfizer and Merck are developing drugs in the space that could ease the trials of cancer treatment and make them big money in the process.
Healthcare costs are expected to rise in 2025 and older adults are increasingly looking to age in place — trends Samsung is targeting to get a bigger piece of the digital health market. And the company’s upcoming smartwatch update is another step in that direction, says Hon Pak, vice president and head of the digital health team for Samsung’s mobile business.
Managing the various symptoms and anxieties that often accompany cancer through music therapy, it turns out, is as effective as traditional cognitive behavioral therapy, according to a study presented at the American Society of Clinical Oncology meeting this month.